Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

20.22
Delayed Data
As of Jan 13
 +0.38 / +1.92%
Today’s Change
14.84
Today|||52-Week Range
33.30
-1.08%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close19.84
Today’s open19.86
Day’s range19.56 - 20.70
Volume275,638
Average volume (3 months)279,102
Market cap$704.4M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-148.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.80+5.76%
INSYINSYS Therapeutics I...-0.13-1.25%
KERXKeryx Biopharmaceuti...+0.03+0.48%
ACRSAclaris Therapeutics...+0.08+0.28%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs